Natera, Inc. NTRA 深 沪
等待开盘 03-27 09:30:00 美东时间
196.15
-1.220
-0.62%
华盛通- 最 高210.51
- 今 开195.36
- 成交量 63.64万股
- 最 低 186.07
- 昨 收 197.37
- 总市值 1889.20万
- 52周最高 256.36
- 市盈率 静 --
- 换手率 660.72%
- 52周最低 125.38
- 委 比 -84.55%
- 总股本 9.63万
- 历史最高 256.36
- 量 比 0
- 振 幅 12.38%
- 历史最低 1.10
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Natera Completes Enrollment In ACES-EMB Study Evaluating Prospera Heart Test
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the completion of enrollment in ACES-EMB, the first randomized-controlled trial evaluating whether Natera's Prospera
01-28 21:06
Natera Advances Molecular Residual Disease-Based Risk Stratification With New Multi-Model
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an advancement in molecular residual disease (MRD)-based risk stratification that is expected to
01-13 21:10
Natera Highlights Signatera Study In Nature Communications
The study examined how Signatera can refine risk assessment in patients with early-stage breast cancer whose tumors resist neoadjuvant therapy (NAT). These cancers often leave behind substantial residual disease and
2025-12-16 21:09
Natera Ends Lawsuit, Clearing Path for NeoGenomics' RaDaR ST Launch
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that Natera voluntarily dismissed its appeal (and NeoGenomics thus dismissed its
2025-12-15 20:24
Natera Buys Foresight To Boost Super-Early Cancer Detection Tech
Natera acquires Foresight Diagnostics for $275 million upfront with potential for $175 million in earnouts.
2025-12-05 23:05
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
调研速递|华大基因接受国联证券等80家机构调研 业绩说明会透露重要业务进展与数据
2025年8月25日15:00 - 16:00，深圳华大基因股份有限公司举办了一场业绩说明会，采用线上电话会议形式，吸引了国联证券、中信证券、兴业证券等80家机...
2025-08-26 09:00
传奇投资人Druckenmiller Q1清仓美国钢铁 增持台积电和Docusign
传奇投资人、杜肯资本创始人斯坦利·德鲁肯米勒(Stanley Druckenmiller)旗下全球顶级家族办公室Duquesne Family Office递交了截至2025年3月31日的第一季度持仓报告(13F)。 据统计，该机构第三季度持仓总市值为30.6亿美元，上一季度总市值为37.2亿美元。该基金在第三季度的投资组合中新增了12只个股，增持了14只个股，减持了18只个股，清仓了38只个股。其中前十大持仓标的占总市值的59.8%。 在Duquesne Family Office的第三季度前五大重仓股中，Natera(NTRA.US)位列第一，持仓340万股，持仓市值约4.81亿美元，占投...
2025-05-16 10:25
Stanley Druckenmiller一季度增持台积电
13F报告显示，Stanley Druckenmiller旗下Duquesne Family Office LLC.一季度建仓做多DocuSign、CCC I...
2025-05-16 06:16
